Nervous System Diseases: Clinical Trials

1,026 trials for Nervous System Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1026 unknown. 1026 Phase 2, 199 Phase 1, 161 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21026Unknown 1026
Phase 1199Unknown 199
Phase 3161Unknown 161

Follow Nervous System Diseases: new trials by email Literature Review of Nervous System Diseases trials Research Report on Nervous System Diseases

Trials (filtered) newest first · largest first

All 1,026 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MRG-001 in Patients With Amyotrophic Lateral Sclerosis
MRG-001 - Amyotrophic Lateral Sclerosis, Lou Gehrig Disease
Phase 2UnknownMedRegen LLC102025-07-012024-08-23
Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke
Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute
Phase 2 / Phase 3UnknownCapital Medical University3022024-11-202024-10-29
Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy
Magnetic Spinal Stimulation - Spastic Cerebral Palsy, Dysarthria
Phase 2 / Phase 3UnknownSociedad Argenttina de Neuromodulación202024-11-182023-11-21
A Study to Evaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients
IMC-002, mycophenolate mofetil, MMF - Neuromyelitis Optica Spectrum Disorder (NMOSD)
Phase 1 / Phase 2UnknownImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.1162024-10-102024-08-16
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age
LR20062, DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus
Phase 2UnknownLG Chem3362024-10-022024-10-01
A Randomized, Placebo-controlled Trial of Prednisone in Refractory Restless Legs Syndrome: a Pilot Study
Prednisone, Placebo - Restless Legs Syndrome
Phase 1 / Phase 2UnknownScripps Health502024-10-012024-10-08
Cilostazol in Parkinson's Disease
Cilostazol, Placebo, Standard treatment - Parkinson's Disease
Phase 2UnknownAin Shams University502024-10-012024-09-25
Black Seed Oil in ADHD
Atomoxetine, Black Seed Oil Cap/Tab - ADHD
Phase 2UnknownAin Shams University602024-10-012024-08-09
Node-Sparing Short-Course Radiation With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer: A Randomized, Prospective, Multicenter Study
Node-Sparing Short-Course Radiotherapy Combined with CAPOX and Sintilimab, CAPOX Chemotherapy - Microsatellite Stable (MSS) Colon Cancer, Locally Advanced Colon Cancer
Phase 2UnknownSir Run Run Shaw Hospital1402024-10-012024-09-19
Lidocaine Versus Magnesium Sulphate in Management of Myofascial Pain Dysfunction Syndrome
Magnesium sulphate, Lidocaine (drug), Saline - Myofascial Pain Dysfunction Syndrome
Phase 2UnknownMisr University for Science and Technology752024-10-012024-09-19
Cannabidiol's Role in Dementia Management
Cannabidiol Oil - Dementia, Vascular, Dementia, Mixed
Phase 2 / Phase 3UnknownHospital Pengajar Universiti Putra Malaysia4862024-09-012024-07-23
Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients
Salbutamol, Placebo - Walking Capacity, Amyotrophic Lateral Sclerosis
Phase 2UnknownAssistance Publique - Hôpitaux de Paris362024-09-012024-04-12
Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries
Ketamine, Dexmedetomidine - Emergence Delirium
Phase 1 / Phase 2UnknownCairo University462024-08-102024-08-20
ADC-induced Neurotoxicity Treated With Duloxetine
duloxetine - Solid Tumour
Phase 2UnknownFudan University372024-08-062024-09-19
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B )
Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit adherent to guidelines - Ischemic Stroke, Acute
Phase 2UnknownYongjun Wang1002024-08-042024-08-12
The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage
Rapamycin - Communicating Hydrocephalus, Cerebral Intraventricular Hemorrhage
Phase 2UnknownBeijing Tiantan Hospital532024-08-012024-08-21
Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3
Eliglustat Tartrate Capsules - Gaucher Disease
Phase 2UnknownPeking Union Medical College Hospital52024-08-012024-07-26
Study of the Drug B11-FC (Botulism Treatment)
B11-FC, Botulinum neurotoxin type A, Placebo - Botulism
Phase 1 / Phase 2UnknownGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation402024-08-012024-08-30
Early Interferon-beta Treatment for West-Nile Virus Infection
Rebif 44 MCG Per 0.5 ML Prefilled Syringe, Saline - West Nile Virus, West Nile Fever Encephalitis
Phase 2UnknownTel-Aviv Sourasky Medical Center1002024-07-142024-07-23
FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack
Efgartigimod Alfa Injection, High-dose intravenous methylprednisolone - Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder
Phase 2UnknownTianjin Medical University General Hospital632024-07-052024-07-11

Showing 20 of 1026. Sign in to see all of them.

Narrower conditions

Brain Neoplasms (87)  ·  Stroke (82)  ·  Parkinson Disease (70)  ·  Ischemic Stroke (68)  ·  Alzheimer Disease (61)  ·  Spinal Cord Injuries (35)  ·  Multiple Sclerosis (33)  ·  Amyotrophic Lateral Sclerosis (28)  ·  Central Nervous System Neoplasms (28)  ·  Agnosia (25)  ·  Carcinoma, Non-Small-Cell Lung (25)  ·  Cognitive Dysfunction (23)  ·  Brain Injuries, Traumatic (22)  ·  Cerebral Palsy (20)  ·  Glioblastoma (20)

Broader conditions

Central Nervous System Diseases (643)  ·  Brain Diseases (555)  ·  Pathological Conditions, Signs and Symptoms (339)  ·  Signs and Symptoms (236)  ·  Neurologic Manifestations (226)  ·  Cardiovascular Diseases (212)  ·  Vascular Diseases (204)  ·  Neurodegenerative Diseases (199)  ·  Cerebrovascular Disorders (179)  ·  Neuromuscular Diseases (152)  ·  Neoplasms (151)  ·  Mental Disorders (147)  ·  Neoplasms by Site (139)  ·  Pathologic Processes (139)

Interventions

Sodium Chloride (22)  ·  Radiotherapy (21)  ·  Transcranial Direct Current Stimulation (19)  ·  Saline Solution (17)  ·  Dexamethasone (15)  ·  Temozolomide (14)  ·  Aspirin (12)  ·  Botulinum Toxins, Type A (12)  ·  Melatonin (11)  ·  Dexmedetomidine (10)  ·  Bevacizumab (9)  ·  Carboplatin (9)  ·  Donepezil (9)  ·  Standard of Care (9)  ·  Bupivacaine (8)

Sponsors

University of Calgary (16)  ·  Beijing Tiantan Hospital (13)  ·  Chang Gung Memorial Hospital (13)  ·  Fudan University (11)  ·  Capital Medical University (10)  ·  Chaitanya Hospital, Pune (10)  ·  Children's Cancer and Leukaemia Group (9)  ·  Hadassah Medical Organization (9)  ·  Tel-Aviv Sourasky Medical Center (9)  ·  University Hospital, Clermont-Ferrand (9)  ·  National Taiwan University Hospital (8)  ·  Seoul National University Hospital (8)  ·  Ain Shams University (7)  ·  Assiut University (7)  ·  Peking University Third Hospital (7)

Countries

China (187)  ·  United States (181)  ·  Canada (66)  ·  France (40)  ·  Israel (38)  ·  Brazil (35)  ·  South Korea (35)  ·  United Kingdom (35)  ·  Italy (31)  ·  Germany (28)  ·  Egypt (25)  ·  India (24)  ·  Taiwan (24)  ·  Netherlands (23)  ·  Denmark (15)

Top investigators

Dongsheng Fan (3)  ·  Gang Zhao, M.D. (3)  ·  Limin Rong, M.D. (3)  ·  Liu Anwen, Phd (3)  ·  Sven Poli, Dr. med. (3)  ·  Zhanguo Li (3)  ·  Abraham Lieberman, MD (2)  ·  Andrey S. Bryukhovetskiy, MD (2)  ·  Anthony Cardile, DO (2)  ·  Anthony Michalski, MD (2)  ·  Barry Pizer, MD (2)

Results publications

PMID 25303679, PMID 25789053, PMID 33175411, PMID 37870112, PMID 38648030, PMID 10655437, PMID 10917410, PMID 11105983, PMID 11231629, PMID 11399225, PMID 11402097, PMID 11452123, PMID 11937316, PMID 12177103, PMID 12434281, PMID 12465055, PMID 12529557, PMID 12542793, PMID 12750523, PMID 12849360, PMID 12873949, PMID 14506149, PMID 1463007, PMID 15026214, PMID 15030944, PMID 15037681, PMID 1517644, PMID 15212606, PMID 15234492, PMID 15328899, PMID 15496622, PMID 15714427, PMID 15809479, PMID 15864738, PMID 15919269, PMID 16011702, PMID 16078267, PMID 16108461, PMID 16214880, PMID 16265674, PMID 16282547, PMID 16336965, PMID 16510333, PMID 16521220, PMID 16574919, PMID 16598416, PMID 16645718, PMID 1674640, PMID 16757720, PMID 16793729

NIH funding

2016 (6), 2019 (5), 2018 (4), 2015 (3), 2005 (2), 2008 (2), 2014 (2), 2017 (2), 2009 (1), M01RR000036 (1), P30AG024978 (1), P30CA033572 (1), P30CA060553 (1), R01AG025502 (1), R01AG043398 (1)